{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:13:05Z","timestamp":1788491585961,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFD155"],"award-info":[{"award-number":["2023AFD155"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ginseng Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jgr.2026.101055","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:04:02Z","timestamp":1777932242000},"page":"101055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ginsenosides: potential therapeutic agents against hepatic fibrosis"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5582-305X","authenticated-orcid":false,"given":"Zhengzheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgr.2026.101055_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101231","article-title":"Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies","volume":"95","author":"Parola","year":"2024","journal-title":"Mol Aspect Med"},{"issue":"10","key":"10.1016\/j.jgr.2026.101055_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jgr.2026.101055_bib3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jgr.2026.101055_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jgr.2026.101055_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgr.2026.101055_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104720","article-title":"Intercellular crosstalk of hepatic stellate cells in liver fibrosis: new insights into therapy","volume":"155","author":"Cai","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jgr.2026.101055_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122547","article-title":"The evidence-based multifaceted roles of hepatic stellate cells in liver diseases: a concise review","volume":"344","author":"Kim","year":"2024","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.jgr.2026.101055_bib8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jgr.2025.08.007","article-title":"Protective effects of ginsenosides in cerebral small vessel disease: cellular and molecular mechanisms","volume":"49","author":"Zhai","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101055_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155289","article-title":"Ginsenoside Rg3 promotes hepatic stellate cell ferroptosis by epigenetically regulating ACSL4 to suppress liver fibrosis progression","volume":"124","author":"Hu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jgr.2026.101055_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154950","article-title":"Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11","volume":"118","author":"Lang","year":"2023","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.jgr.2026.101055_bib11","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1021\/acs.jafc.2c06804","article-title":"Ginsenoside AD-2 ameliorating lipopolysaccharide-induced activation in HSC-T6 cells and carbon tetrachloride-induced hepatic fibrosis in mice via regulation of VD-VDR axis","volume":"71","author":"Chen","year":"2023","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jgr.2026.101055_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156204","article-title":"Efficacy and safety of YOXINTINE for depression: a double-blinded, randomized, placebo-controlled, phase 2 clinical trial","volume":"136","author":"Dong","year":"2025","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.jgr.2026.101055_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30122527","article-title":"Therapeutic potential of ginsenosides in anthracycline-induced cardiotoxicity","volume":"30","author":"Bai","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.jgr.2026.101055_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115340","article-title":"Ginsenosides in endometrium-related diseases: emerging roles and mechanisms","volume":"166","author":"Zhang","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.jgr.2026.101055_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062593","article-title":"Anti-colorectal cancer activity of panax and its active components, ginsenosides: a review","volume":"26","author":"Kang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jgr.2026.101055_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105647","article-title":"Ginsenosides in vascular remodeling: cellular and molecular mechanisms of their therapeutic action","volume":"169","author":"Zhu","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jgr.2026.101055_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3389\/fphar.2020.00834","article-title":"Comparison of the protective effects of ginsenosides Rb1 and Rg1 on improving cognitive deficits in SAMP8 mice based on anti-neuroinflammation mechanism","volume":"11","author":"Yang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"20","key":"10.1016\/j.jgr.2026.101055_bib18","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1039\/D3FO02482B","article-title":"Ginsenosides: a potential natural medicine to protect the lungs from lung cancer and inflammatory lung disease","volume":"14","author":"Wang","year":"2023","journal-title":"Food Funct"},{"issue":"1","key":"10.1016\/j.jgr.2026.101055_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/aps.2008.6","article-title":"Effect of sugar positions in ginsenosides and their inhibitory potency on Na+\/K+-ATPase activity","volume":"30","author":"Chen","year":"2009","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.jgr.2026.101055_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-9861(02)00398-3","article-title":"Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line","volume":"406","author":"Popovich","year":"2002","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"10.1016\/j.jgr.2026.101055_bib21","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1111\/jcmm.13601","article-title":"Ginsenoside Rg3 stereoisomers differentially inhibit vascular smooth muscle cell proliferation and migration in diabetic atherosclerosis","volume":"22","author":"Guo","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jgr.2026.101055_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yrtph.2017.11.007","article-title":"Subchronic oral toxicity study of Korean red ginseng extract in Sprague-Dawley rats with a 4-week recovery period","volume":"92","author":"Park","year":"2018","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.jgr.2026.101055_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104812","article-title":"Thirteen-week oral toxicity study of fermented ginseng, GBCK25, in Sprague-Dawley rats","volume":"118","author":"Kim","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.jgr.2026.101055_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115429","article-title":"Safety evaluation of rare ginsenosides of stems and leaves from American ginseng: 90-day exposure toxicity study combined with intestinal flora analysis and metabonomics in rats","volume":"264","author":"Cao","year":"2023","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.jgr.2026.101055_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110578","article-title":"Preclinical safety of ginsenoside compound K: acute, and 26-week oral toxicity studies in mice and rats","volume":"131","author":"Gao","year":"2019","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jgr.2026.101055_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104522","article-title":"A 26-week 20(S)-ginsenoside Rg3 oral toxicity study in Beagle dogs","volume":"110","author":"Gao","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.jgr.2026.101055_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112323","article-title":"Repeated-dose 26-week oral toxicity study of ginsenoside compound K in Beagle dogs","volume":"248","author":"Li","year":"2020","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.jgr.2026.101055_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2025.101637","article-title":"Targeting LOXL1-expressing hepatic stellate cell inhibits fibrogenesis and sinusoid angiogenesis via LOXL1\/RUNX1\/VEGFA axis during progression of liver fibrosis","volume":"20","author":"Yan","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.jgr.2026.101055_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111419","article-title":"TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.jgr.2026.101055_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9081014","article-title":"Extra- and intra-cellular mechanisms of hepatic stellate cell activation","volume":"9","author":"Yan","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.jgr.2026.101055_bib31","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41401-024-01454-x","article-title":"Peptidoglycan isolated from the fruit of Lycium barbarum alleviates liver fibrosis in mice by regulating the TGF-\u03b2\/Smad7 signaling and gut microbiota","volume":"46","author":"Nie","year":"2025","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.jgr.2026.101055_bib32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jgr.2022.12.005","article-title":"Ginsenoside Rg1 epigenetically modulates Smad7 expression in liver fibrosis via MicroRNA-152","volume":"47","author":"Zhang","year":"2023","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101055_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123062","article-title":"Vitamin D as a modulator of molecular pathways involved in CVDs: evidence from preclinical studies","volume":"357","author":"Anilkumar","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.jgr.2026.101055_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ijbiomac.2021.11.098","article-title":"Ginsenoside PPD inhibit the activation of HSCs by directly targeting TGF\u03b2R1","volume":"194","author":"Yuan","year":"2022","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10.1016\/j.jgr.2026.101055_bib35","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/s42003-025-08814-1","article-title":"BCL11A deficiency protects epidermis from UVB-induced damage through promotion of autophagy","volume":"8","author":"Deng","year":"2025","journal-title":"Commun Biol"},{"issue":"3","key":"10.1016\/j.jgr.2026.101055_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ph18030287","article-title":"Micheliolide alleviates hepatic fibrosis by inhibiting autophagy in hepatic stellate cells via the TrxR1\/2-Mediated ROS\/MEK\/ERK pathway","volume":"18","author":"Liu","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.jgr.2026.101055_bib37","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41419-020-2597-7","article-title":"Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis"},{"issue":"11","key":"10.1016\/j.jgr.2026.101055_bib38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.molmed.2023.08.001","article-title":"ROS\/RNS as molecular signatures of chronic liver diseases","volume":"29","author":"Che","year":"2023","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.jgr.2026.101055_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/biof.1432","article-title":"Ginsenoside Rg1 ameliorates liver fibrosis via suppressing epithelial to mesenchymal transition and reactive oxygen species production in vitro and in vivo","volume":"44","author":"Wei","year":"2018","journal-title":"Biofactors"},{"issue":"8","key":"10.1016\/j.jgr.2026.101055_bib40","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/aps.2014.41","article-title":"Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis","volume":"35","author":"Li","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jgr.2026.101055_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107571","article-title":"Ginsenoside Rg1: a bioactive therapeutic agent for diverse liver diseases","volume":"212","author":"Wu","year":"2025","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jgr.2026.101055_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202509989","article-title":"Lactate metabolic reprogramming mediated by CircRNA-LDHA complex facilitates innate immune evasion of liver cancer","author":"Shen","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"10.1016\/j.jgr.2026.101055_bib43","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.jgr.2026.101055_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156223","article-title":"Ginsenoside compound K restrains hepatic fibrotic response by dual-inhibition of GLS1 and LDHA","volume":"135","author":"Wu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jgr.2026.101055_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107911","article-title":"CROT overactivation within peroxisomes confers chemoresistance to non-small cell lung cancer by targeting fatty acid oxidation-Nrf2-ferroptosis resistance axis","volume":"220","author":"Hua","year":"2025","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.jgr.2026.101055_bib46","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/s42003-025-08421-0","article-title":"Astragalin promotes HSCs ferroptosis through NCOA4 mediated ferritinophagy to alleviate liver fibrosis in zebrafish and mice","volume":"8","author":"Wang","year":"2025","journal-title":"Commun Biol"},{"issue":"27","key":"10.1016\/j.jgr.2026.101055_bib47","doi-asserted-by":"crossref","first-page":"17205","DOI":"10.1021\/acs.jafc.5c00107","article-title":"Ginsenoside RK1 promotes hepatic stellate cell glycolysis-mediated ferroptosis by activating the HK2\/ACSL4\/LPCAT3\/ALOX5 signaling pathway","volume":"73","author":"Xia","year":"2025","journal-title":"J Agric Food Chem"},{"issue":"5","key":"10.1016\/j.jgr.2026.101055_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2023.11.009","article-title":"Ginsenoside Rb1 induces hepatic stellate cell ferroptosis to alleviate liver fibrosis via the BECN1\/SLC7A11 axis","volume":"14","author":"Lin","year":"2024","journal-title":"J Pharm Anal"},{"issue":"3","key":"10.1016\/j.jgr.2026.101055_bib49","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/ptr.8106","article-title":"Ginkgetin exhibits antifibrotic effects by inducing hepatic stellate cell apoptosis via STAT1 activation","volume":"38","author":"Wang","year":"2024","journal-title":"Phytother Res"},{"issue":"3","key":"10.1016\/j.jgr.2026.101055_bib50","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jgr.2017.01.012","article-title":"20S-Protopanaxadiol, an aglycosylated ginsenoside metabolite, induces hepatic stellate cell apoptosis through liver kinase B1-AMP-activated protein kinase activation","volume":"41","author":"Park","year":"2017","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101055_bib51","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jare.2024.12.016","article-title":"Natural small molecule hinokitone mitigates NASH fibrosis by targeting regulation of FXR-mediated hepatocyte apoptosis","volume":"76","author":"Ma","year":"2025","journal-title":"J Adv Res"},{"key":"10.1016\/j.jgr.2026.101055_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155287","article-title":"Ginsenoside Rg5 inhibits lipid accumulation and hepatocyte apoptosis via the Notch 1 signaling pathway in NASH mice","volume":"124","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jgr.2026.101055_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107155","article-title":"SIRT1: harnessing multiple pathways to hinder NAFLD","volume":"203","author":"Tian","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jgr.2026.101055_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122291","article-title":"Long-term and liver-selected ginsenoside C-K nanoparticles retard NAFLD progression by restoring lipid homeostasis","volume":"301","author":"Yue","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jgr.2026.101055_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117794","article-title":"Ginsenoside Rg1 attenuates lipopolysaccharide-induced chronic liver damage by activating Nrf2 signaling and inhibiting inflammasomes in hepatic cells","volume":"324","author":"Zhou","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jgr.2026.101055_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106092","article-title":"Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway","volume":"177","author":"Xiang","year":"2022","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.jgr.2026.101055_bib57","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12441","article-title":"Ginsenoside Rg1 ameliorates aging-induced liver fibrosis by inhibiting the NOX4\/NLRP3 inflammasome in SAMP8 mice","volume":"24","author":"Li","year":"2021","journal-title":"Mol Med Rep"},{"issue":"27","key":"10.1016\/j.jgr.2026.101055_bib58","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.1021\/acs.jafc.8b01982","article-title":"Ginsenoside 25-OCH(3)-PPD promotes activity of LXRs to ameliorate P2X7R-Mediated NLRP3 inflammasome in the development of hepatic fibrosis","volume":"66","author":"Han","year":"2018","journal-title":"J Agric Food Chem"},{"issue":"12","key":"10.1016\/j.jgr.2026.101055_bib59","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1039\/D3FO01315D","article-title":"Ginsenoside Rd, a natural production for attenuating fibrogenesis and inflammation in hepatic fibrosis by regulating the ERR\u03b1-mediated P2X7r pathway","volume":"14","author":"Cui","year":"2023","journal-title":"Food Funct"},{"issue":"3","key":"10.1016\/j.jgr.2026.101055_bib60","first-page":"367","article-title":"Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR\/LXR-mediated P2X7R\/NLRP3\/NF-\u03baB pathway activation","volume":"14","author":"Bao","year":"2022","journal-title":"Chin Herb Med"},{"issue":"1","key":"10.1016\/j.jgr.2026.101055_bib61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12974-024-03056-0","article-title":"LXR agonism for CNS diseases: promises and challenges","volume":"21","author":"Zhang","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jgr.2026.101055_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1592203","article-title":"Ginsenoside re ameliorates thioacetamide-induced acute liver injury through inhibiting autophagy-NLRP3 inflammasome pathway","volume":"16","author":"Lin","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jgr.2026.101055_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157552","article-title":"Ginsenoside Rg2 ameliorates metabolic dysfunction-related steatohepatitis via the Nrf2 pathway by suppressing inflammation, apoptosis, oxidative stress and fibrosis","volume":"149","author":"Chen","year":"2025","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.jgr.2026.101055_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2024.101379","article-title":"Microbial-derived urolithin A targets GLS1 to inhibit glutaminolysis and attenuate cirrhotic portal hypertension","volume":"18","author":"Li","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.jgr.2026.101055_bib65","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41423-025-01339-x","article-title":"Gut-derived indole propionic acid alleviates liver fibrosis by targeting profibrogenic macrophages via the gut\u2012liver axis","volume":"22","author":"Luo","year":"2025","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"10.1016\/j.jgr.2026.101055_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167914","article-title":"Extracellular vesicle-dependent crosstalk between hepatic stellate cells and Kupffer cells promotes their mutual activation","volume":"1871","author":"Wang","year":"2025","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jgr.2026.101055_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106621","article-title":"Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation","volume":"187","author":"Yan","year":"2023","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.jgr.2026.101055_bib68","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/HEP.0000000000000985","article-title":"Intestinal IL-33 promotes microbiota-derived trimethylamine N -oxide synthesis and drives metabolic dysfunction-associated steatotic liver disease progression by exerting dual regulation on HIF-1\u03b1","volume":"82","author":"Hai","year":"2025","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jgr.2026.101055_bib69","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1016\/j.apsb.2023.07.027","article-title":"MANF brakes TLR4 signaling by competitively binding S100A8 with S100A9 to regulate macrophage phenotypes in hepatic fibrosis","volume":"13","author":"Hou","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"10.1016\/j.jgr.2026.101055_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/nu17111844","article-title":"Mechanism of ginsenoside Rg(1) in regulating the metabolic function of intestinal flora for the treatment of high-purine dietary hyperuricemia","volume":"17","author":"Sun","year":"2025","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jgr.2026.101055_bib71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.apsb.2024.10.010","article-title":"Akkermansia muciniphila-derived acetate activates the hepatic AMPK\/SIRT1\/PGC-1\u03b1 axis to alleviate ferroptosis in metabolic-associated fatty liver disease","volume":"15","author":"Zhuge","year":"2025","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.jgr.2026.101055_bib72","doi-asserted-by":"crossref","DOI":"10.1093\/lifemeta\/loaf036","article-title":"Propionic acid secreted by Akkermansia muciniphila alleviates hepatic fibrosis by antioxidant regulation across the gut-liver axis","volume":"5","author":"Zhang","year":"2026","journal-title":"Life Metab"},{"issue":"4","key":"10.1016\/j.jgr.2026.101055_bib73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.hbpd.2025.04.006","article-title":"Sodium butyrate ameliorates liver fibrosis in metabolic dysfunction-associated steatohepatitis rats via miR-155-5p\/SOCS1\/PDGF signaling pathway","volume":"24","author":"Huang","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jgr.2026.101055_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118903","article-title":"Toll-like receptor 4-mediated inflammatory stimulation in Kupffer cell enhances arsenite-induced liver fibrosis by triggering hepatic stellate cell activation","volume":"303","author":"Song","year":"2025","journal-title":"Ecotoxicol Environ Saf"},{"issue":"11","key":"10.1016\/j.jgr.2026.101055_bib75","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1080\/15548627.2017.1356550","article-title":"Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling","volume":"13","author":"Chen","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.jgr.2026.101055_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154121","article-title":"Ginsenoside Rh2 attenuates CDAHFD-induced liver fibrosis in mice by improving intestinal microbial composition and regulating LPS-mediated autophagy","volume":"101","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"issue":"24","key":"10.1016\/j.jgr.2026.101055_bib77","doi-asserted-by":"crossref","first-page":"9370","DOI":"10.1021\/acs.jafc.3c00789","article-title":"Ginsenoside Rk3 regulates nonalcoholic steatohepatitis by modulation of intestinal flora and the PI3K\/AKT signaling pathway in C57BL\/6 mice","volume":"71","author":"Guo","year":"2023","journal-title":"J Agric Food Chem"},{"issue":"6","key":"10.1016\/j.jgr.2026.101055_bib78","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jgr.2023.07.005","article-title":"Methods on improvements of the poor oral bioavailability of ginsenosides: pre-processing, structural modification, drug combination, and micro- or nano- delivery system","volume":"47","author":"Hu","year":"2023","journal-title":"J Ginseng Res"},{"issue":"5","key":"10.1016\/j.jgr.2026.101055_bib79","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jgr.2025.05.003","article-title":"In vivo metabolism, pharmacokinetics, and pharmacological activities of ginsenosides from ginseng","volume":"49","author":"Wang","year":"2025","journal-title":"J Ginseng Res"}],"container-title":["Journal of Ginseng Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845326000813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845326000813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:20:25Z","timestamp":1788488425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1226845326000813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1226845326000813"],"URL":"https:\/\/doi.org\/10.1016\/j.jgr.2026.101055","relation":{},"ISSN":["1226-8453"],"issn-type":[{"value":"1226-8453","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginsenosides: potential therapeutic agents against hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Ginseng Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgr.2026.101055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Korean Society of Ginseng. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101055"}}